Zhou, Li
Wu, Xiaowen
Chi, Zhihong
Si, Lu
Sheng, Xinan
Kong, Yan
Mao, Lili
Lian, Bin
Tang, Bixia
Yan, Xieqiao
Wang, Xuan
Bai, Xue
Li, Siming
Wei, Xiaoting
Li, Juan
Yang, Qing
Guo, Jun
Cui, Chuanliang
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Beijing Municipal Administration of Hospitals Incubating Program (PX2021046)
Article History
Received: 26 December 2021
Accepted: 9 May 2022
First Online: 20 May 2022
Declarations
:
: This study was approved by the Peking University Cancer Hospital Ethics Committee. Informed Consent to participate was obtained from every participant. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: Qing Yang is a salaried employee of Jiangsu Hengrui Medicine Co. No competing interests were disclosed by the other authors.